dr. apolo on avelumab for metastatic urothelial carcinoma
Published 7 years ago • 195 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
0:43
dr. andrea apolo on avelumab in metastatic bladder cancer
-
1:09
dr. apolo on updated javelin results of avelumab in urothelial carcinoma
-
1:01
dr. andrea apolo on treatment challenges in metastatic bladder cancer
-
1:10
updated efficacy results for avelumab in metastatic urothelial carcinoma
-
2:09
dr. apolo on cabozantinib plus nivolumab and ipilimumab in urothelial carcinoma
-
4:10
pooled analysis of avelumab for metastatic urothelial carcinoma
-
3:26
avelumab for metastatic urothelial carcinoma: javelin trial
-
1:00
dr. apolo on toxicity challenges with checkpoint inhibitors in bladder cancer
-
4:17
metastatic bladder cancer: progression after maintenance
-
1:13
dr. apolo on the safety of nivolumab plus cabozantinib in urothelial carcinoma
-
1:20
pooled analysis of avelumab in bladder cancer
-
1:32
dr. apolo on managing toxicities of checkpoint inhibitors in bladder cancer
-
0:44
unmet needs in bladder cancer in the immunotherapy era
-
0:46
an update on avelumab as monotherapy for urothelial carcinoma
-
1:33
ambassador: pembrolizumab for locally advanced bladder cancer
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
0:56
dr. apolo on immunotherapy combinations with cabozantinib in genitourinary tumors
-
4:46
changing the standard of care in metastatic bladder cancer
-
0:49
dr. apolo on side effects of cabozantinib plus immunotherapy agents in bladder cancer